Clarington Peptides / Archive4 articles
All Articles
Reference material on peptide compounds for research use. Filter by topic below.
Topic
Allbone lossfemale peptides bone densityfemale reproductive healthfertilité féminineGLP-1GLP-1 bone health womenGLP-1 menstrual disruptionhypothalamic amenorrheahypothalamuskisspeptinkisspeptin female hormoneskisspeptinemétabolismeneuroendocrine strategyneuroprotectionosteoporosisovulationoxytocinoxytocin weight losspeptide researchpostmenopausalrégulation hormonalesanté reproductivesemaglutide tirzepatide bone lossSOPKtirzepatide
01
bone loss
Oxytocin's neuroprotective role against GLP-1-associated bone loss in postmenopausal women
Postmenopausal women using GLP-1 agonists for weight loss may face accelerated bone loss. Oxytocin, a neuropeptide with osteoanabolic properties
02
female reproductive health
Kisspeptin as a neuroendocrine strategy to counter GLP-1-induced menstrual disruptions in women
GLP-1 agonists like semaglutide and tirzepatide can disrupt menstrual cycles by suppressing hypothalamic kisspeptin. Research explores kisspeptin and
03
female peptides bone density
Oxytocin vs. GLP-1 for Female Weight Loss: Bone Health Divergence
Oxytocin and GLP-1 agonists suppress appetite differently, with divergent bone health outcomes in women. Oxytocin signals directly on bone cells; GLP-1 drugs do not.
04
fertilité féminine
Kisspeptine et régulation hormonale féminine : au-delà des GLP-1
La kisspeptine, peptide méconnu de l'hypothalamus, orchestre fertilité et métabolisme féminin bien au-delà des GLP-1. Découvrez son rôle essentiel dans l'ovulation et la santé hormonale.